Business Segments Mesa Laboratories, Inc.
Stocks
MLAB
US59064R1095
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 108.86 USD | +1.40% |
|
-1.63% | +36.75% |
Sales 2026 by Business Segment
Sales 2026 by Geography
Historical Breakdown of Revenue by Business Segments
Gross Profit: Breakdown by Business Segment
| Fiscal Period: March | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
Medical Equipment | ||||||||||
Sterilization and Disinfection Control | 59.04M | 64.61M | 75.12M | 93.42M | 102M | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
Gross Profit | 43.72M | 46.52M | 53.3M | 64.66M | 71.71M | |||||
D&A | - | - | - | 1.92M | 2.3M | |||||
Medical Testing, Analyzing, and Diagnostic Equipment | ||||||||||
Calibration Solutions | 46.87M | 44.81M | 47.76M | 51.75M | 53.55M | |||||
Gross Profit | 24.99M | 24.39M | 27.55M | 30.64M | 31.98M | |||||
D&A | - | - | - | 837K | 448K | |||||
Instruments | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
Gross Profit | - | - | - | - | - | |||||
D&A | - | - | - | - | - | |||||
Life Sciences Tools and Services | ||||||||||
Biopharmaceutical Development | 45.58M | 47.36M | 40.71M | 48.73M | 48.63M | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
Gross Profit | 28.6M | 30.34M | 25.4M | 29.91M | 28.55M | |||||
D&A | - | - | - | 1.6M | 1.82M | |||||
Clinical Genomics | 32.84M | 62.3M | 52.59M | 47.08M | 45.39M | |||||
Gross Profit | 11.94M | 32.48M | 27.08M | 25.67M | 26.03M | |||||
D&A | - | - | - | 1.44M | 1.34M | |||||
Plastic Packaging | ||||||||||
Cold Chain Packaging | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
Gross Profit | - | - | - | - | - | |||||
Measuring, Analyzing, and Controlling Instruments | ||||||||||
Continuous Monitoring | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
Gross Profit | - | - | - | - | - | |||||
D&A | - | - | - | - | - | |||||
Corporate and Other | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
Gross Profit | -165K | -40K | -77K | -10K | - | |||||
D&A | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - |
Geographical Revenue Distribution History
| Fiscal Period: March | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
United States | 99.07M | 117M | 106M | 117M | 117M | |||||
Total Assets | 36.48M | 34.73M | 32.23M | 29.2M | 29.89M | |||||
Other | - | 76M | 84.86M | 99.05M | 112M | |||||
Total Assets | - | - | 2.48M | 1.17M | 1.21M | |||||
China | - | 25.8M | 24.93M | 25.31M | 20.45M | |||||
Total Assets | - | - | 7.6M | 6.71M | 5.96M | |||||
Total Assets | - | - | - | 11.63M | 10.86M | |||||
Foreign | 85.27M | - | - | - | - | |||||
Total Assets | 3.98M | 3.79M | - | - | - |
- Stock Market
- Stocks
- MLAB Stock
- Financials Mesa Laboratories, Inc.
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
















